Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
YungShin Global Holding CoTPE:3705 +0.18%86 EV-to-EBIT is 10.74 as of Aug. 25, 2026, which is 13% below its 10-year median of 12.35. GuruFocus rates TPE:3705 with a GF Score™ of 86/100 and a GF Value™ of NT$53.89 (Fairly Valued). The stock has 5 warning signs investors should review. Among 690 Drug Manufacturers companies, YungShin Global Holding Co ranks better than 66.23% on this metric.
YungShin Global Holding Co (TPE:3705) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
YungShin Global Holding Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$13,457 Mil.
YungShin Global Holding Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,303 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YungShin Global Holding Co EV-to-EBIT Related Terms
YungShin Global Holding Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, YungShin Global Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YungShin Global Holding Co EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, YungShin Global Holding Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where YungShin Global Holding Co's EV-to-EBIT falls into.
YungShin Global Holding Co's current Enterprise Value is NT$13,990 Mil.
YungShin Global Holding Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,303 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YungShin Global Holding Co (TPE:3705) has a EV-to-EBIT of 10.74 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on YungShin Global Holding Co and its competitors. This is 13% below median its historical median of 12.35. Over the past decade, YungShin Global Holding Co's EV-to-EBIT has ranged from 8.44 to 20.61. According to the industry distribution chart, YungShin Global Holding Co ranks #233 out of 690 companies in the Drug Manufacturers industry, placing it in the top 33.8%.
Is YungShin Global Holding Co's EV-to-EBIT too high?
YungShin Global Holding Co's current EV-to-EBIT of 10.74 is 13% below median its 10-year median of 12.35. Over the past 10 years, this metric has ranged from a low of 8.44 to a high of 20.61. The Drug Manufacturers industry median EV-to-EBIT is 15.81. YungShin Global Holding Co's value of 10.74 is 32.1% below this industry median. Based on the distribution chart, YungShin Global Holding Co ranks #233 out of 690 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, YungShin Global Holding Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does YungShin Global Holding Co's EV-to-EBIT compare to ZTS?
According to the Drug Manufacturers industry distribution chart, YungShin Global Holding Co ranks #233 out of 690 companies for EV-to-EBIT. This puts YungShin Global Holding Co in the upper half of its industry. The industry median EV-to-EBIT is 15.81. YungShin Global Holding Co's value of 10.74 is 32.1% below this benchmark. Historically, YungShin Global Holding Co's own EV-to-EBIT has ranged from 8.44 to 20.61 over the past decade. While the company's 10-year median is 12.35 vs. the industry median of 15.81, YungShin Global Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.81, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. YungShin Global Holding Co's current EV-to-EBIT of 10.74 is 32.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on YungShin Global Holding Co and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YungShin Global Holding Co's current EV-to-EBIT is 10.74, which is 13% below median its own 10-year median of 12.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YungShin Global Holding Co stock overvalued right now?
Based on GuruFocus' analysis, YungShin Global Holding Co (TPE:3705) is currently considered Fairly Valued. The stock's GF Value™ is NT$53.89, compared to a current price of NT$55.80 — trading 3.5% above its estimated fair value. The current EV-to-EBIT is 10.74, which is 13% below median its 10-year median of 12.35 and 32.1% below the Drug Manufacturers industry median of 15.81. YungShin Global Holding Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For YungShin Global Holding Co (TPE:3705), the current EV-to-EBIT is 10.74 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?
Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be overvalued.
The current stock price of NT$55.80 is trading 3.5% above its estimated GF Value™ of NT$53.89.
GuruFocus considers YungShin Global Holding Co to be Fairly Valued.
Key valuation signals for TPE:3705:
EV-to-EBIT: 10.74 (13% below median its 10-year median of 12.35)
GF Value™: NT$53.89 vs. price of NT$55.80 (3.5% above fair value)
Industry Position: 32.1% below the Drug Manufacturers median (#233 of 690)
No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
86GF Score
Get the complete analysis for TPE:3705
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3705 has been successfully added to your 
